SMTL ID : 7ovd.1

Human soluble adenylyl cyclase in complex with the inhibitor TDI10229

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x 1S2: 4-chloranyl-6-[1,5-dimethyl-4-(phenylmethyl)pyrazol-3-yl]pyrimidin-2-amine(Non-covalent)

1S2.1: 16 residues within 4Å: Chain A: F.45, K.95, F.96, A.97, A.100, L.101, L.102, F.165, L.166, V.167, V.172, V.175, R.176, F.336, M.337, F.338 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.45, A:K.95, A:L.102, A:V.172, A:V.175, A:R.176, A:F.336, A:F.336, A:F.338 Hydrogen bonds: A:V.167, A:M.337, A:M.337

4 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 5 residues within 4Å: Chain A: K.95, H.164, N.333, K.334, V.335 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.335 Water bridges: A:K.95 Salt bridges: A:K.95, A:H.164 ACT.8: 6 residues within 4Å: Chain A: L.87, I.88, Y.240, K.246, L.248, L.249 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.249 Hydrogen bonds: A:P.241 ACT.9: 6 residues within 4Å: Chain A: N.298, F.338, G.341, S.343, M.418, M.419 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.338 Hydrogen bonds: A:N.298, A:S.343 ACT.15: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

4 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.3: 4 residues within 4Å: Chain A: I.88, F.89, D.227, F.230 2 PLIP interactions: 2 interactions with chain A pi-Cation interactions: A:F.89, A:F.230 DMS.4: 6 residues within 4Å: Chain A: I.24, G.27, F.29, L.261, S.264, Y.268 1 PLIP interactions: 1 interactions with chain A pi-Cation interactions: A:F.29 DMS.5: 3 residues within 4Å: Chain A: S.80, H.398, T.399 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.80 pi-Cation interactions: A:H.398 DMS.11: 5 residues within 4Å: Chain A: Y.77, H.78, A.81, L.129, F.130 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.78

6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.6: 6 residues within 4Å: Chain A: D.22, G.90, D.92, M.237, Y.239, Y.240 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.22, A:D.22, A:Y.239 EDO.7: 6 residues within 4Å: Chain A: H.162, H.164, Y.318, T.322, Q.331, I.332 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:H.164, A:Y.318, A:T.322, A:G.330, A:I.332 EDO.10: 5 residues within 4Å: Chain A: F.39, D.40, R.106, V.107, E.108 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.40, A:D.40, A:R.106 EDO.12: 3 residues within 4Å: Chain A: F.230, T.231, T.234 No protein-ligand interaction detected (PLIP) EDO.13: 4 residues within 4Å: Chain A: H.19, F.165, Y.268, E.403 1 PLIP interactions: 1 interactions with chain A Water bridges: A:K.95 EDO.14: 5 residues within 4Å: Chain A: T.254, L.255, K.256, D.258, L.261 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.256, A:D.258

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fushimi, M. et al., Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10). Acs Med.Chem.Lett. (2021)

Release Date

2021-10-06

Peptides

Adenylate cyclase type 10: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Adenylate cyclase type 10

Related Entries With Identical Sequence